HbA1c Test: Normal Range, Diabetes, NGSP, IFCC & eAG
A laboratory-focused guide to HbA1c interpretation, NGSP and IFCC standardization, estimated average glucose, testing methods, quality considerations and common analytical limitations.
For nonpregnant individuals, an HbA1c below 5.7% is below the prediabetes range, 5.7–6.4% is the prediabetes range, and 6.5% or higher meets the diabetes diagnostic threshold when appropriate standardized testing and confirmation criteria are satisfied.
What Is HbA1c?
HbA1c, also called glycated hemoglobin or A1C, is a laboratory measurement used to assess longer-term glycemic exposure.
Glucose becomes nonenzymatically attached to hemoglobin within red blood cells. Because erythrocytes circulate for approximately 120 days, HbA1c provides a weighted indication of glucose exposure over the preceding several weeks to months, with more recent glucose levels contributing more strongly to the result.
HbA1c is widely used for diabetes screening, diagnosis in appropriate settings, and monitoring of glycemic management.
Need to convert HbA1c into estimated average glucose? LabProSuite HbA1c to eAG Calculator calculates eAG in mg/dL and mmol/L using the ADAG relationship.
How Is HbA1c Formed?
HbA1c forms through a nonenzymatic glycation process in which glucose reacts with hemoglobin. The proportion of glycated hemoglobin generally increases as average glucose exposure increases.
Because the process is related to circulating glucose exposure and erythrocyte lifespan, HbA1c is different from a single plasma glucose measurement.
What Does HbA1c Measure?
HbA1c provides an indirect measure of average glycemic exposure over the lifespan of circulating erythrocytes. It is a weighted average, with glucose exposure during recent weeks having a greater influence than glucose exposure several months earlier.
Unlike fasting plasma glucose, HbA1c testing generally does not require fasting. However, conditions affecting hemoglobin concentration, erythrocyte turnover or the analytical measurement can influence interpretation.
HbA1c Normal Range, Prediabetes and Diabetes
For nonpregnant individuals, the American Diabetes Association 2026 Standards of Care define the following A1C categories:
| HbA1c | Interpretation | IFCC |
|---|---|---|
| Below 5.7% | Below the prediabetes range | Below 39 mmol/mol |
| 5.7–6.4% | Prediabetes | 39–47 mmol/mol |
| ≥6.5% | Diabetes diagnostic threshold | ≥48 mmol/mol |
An HbA1c value of 6.5% or higher meets the laboratory diagnostic threshold for diabetes when measured using an appropriate NGSP-certified method. In the absence of unequivocal hyperglycemia, confirmation with additional abnormal testing is required.
HbA1c for Diabetes Diagnosis
HbA1c is one of the accepted laboratory criteria for diagnosing diabetes in nonpregnant individuals. The 2026 ADA Standards of Care specify that diagnostic HbA1c testing should use a method certified by the National Glycohemoglobin Standardization Program (NGSP) as traceable to the DCCT reference assay.
Other laboratory diagnostic approaches include fasting plasma glucose, 2-hour plasma glucose during a 75-g oral glucose tolerance test, and random plasma glucose in people with classic symptoms of hyperglycemia or hyperglycemic crisis.
A result close to a diagnostic threshold should not be interpreted in isolation. Analytical performance, biological factors and appropriate confirmation requirements should be considered.
HbA1c for Diabetes Monitoring
HbA1c is widely used to monitor longer-term glycemic management in people with diabetes. It complements direct glucose measurements, self-monitoring and continuous glucose monitoring rather than replacing them.
Individual HbA1c treatment targets should be determined clinically and may differ according to patient characteristics, treatment regimen, hypoglycemia risk and comorbid conditions.
What Is NGSP HbA1c?
NGSP stands for the National Glycohemoglobin Standardization Program. Its standardization system links HbA1c measurement to established reference systems, including the DCCT reference.
NGSP HbA1c is commonly reported as a percentage, such as 6.5% or 7.0%.
The NGSP system also provides relationships between HbA1c percentage, IFCC mmol/mol and estimated average glucose.
What Is IFCC HbA1c?
The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) established a reference system for HbA1c measurement.
IFCC HbA1c is reported in mmol/mol, whereas NGSP results are commonly reported as percentages.
The two reporting systems are mathematically related and allow laboratories and clinicians to communicate HbA1c results using different standardized units.
NGSP vs IFCC HbA1c
| System | Unit | Example |
|---|---|---|
| NGSP | % | 7.0% |
| IFCC | mmol/mol | 53 mmol/mol |
An HbA1c value of approximately 7.0% corresponds to approximately 53 mmol/mol in IFCC units.
What Is Estimated Average Glucose (eAG)?
Estimated Average Glucose (eAG) converts an HbA1c result into an estimated average glucose concentration. It can be expressed in mg/dL or mmol/L.
The relationship is derived from the ADAG study and is reported by NGSP.
eAG (mmol/L) ≈ eAG (mg/dL) ÷ 18
HbA1c to eAG Example Calculation
For an HbA1c value of 7.0%:
200.9 − 46.7 = 154.2 mg/dL
154.2 ÷ 18 ≈ 8.6 mmol/L
Therefore, an HbA1c of 7.0% corresponds to an estimated average glucose of approximately 154 mg/dL or 8.6 mmol/L using the ADAG relationship.
HbA1c to eAG Calculator
Enter an HbA1c percentage and calculate estimated average glucose in both mg/dL and mmol/L.
Calculate HbA1c to eAG →HbA1c, IFCC and eAG Conversion Table
| HbA1c (%) | IFCC (mmol/mol) | eAG (mg/dL) | eAG (mmol/L) |
|---|---|---|---|
| 5.0 | 31 | 97 | 5.4 |
| 6.0 | 42 | 126 | 7.0 |
| 7.0 | 53 | 154 | 8.6 |
| 8.0 | 64 | 183 | 10.2 |
| 9.0 | 75 | 212 | 11.8 |
| 10.0 | 86 | 240 | 13.3 |
| 11.0 | 97 | 269 | 14.9 |
| 12.0 | 108 | 298 | 16.6 |
HbA1c Laboratory Testing Methods
HbA1c can be measured using several analytical technologies. The major approaches used in clinical laboratories include:
- High-performance liquid chromatography (HPLC)
- Immunoassay
- Enzymatic HbA1c methods
- Capillary electrophoresis
The analytical principle, calibration system, separation characteristics and susceptibility to interference differ between methods.
For laboratory professionals, the important consideration is not simply the instrument technology but whether the method is appropriately standardized, validated and suitable for the intended clinical use.
HbA1c by HPLC
High-performance liquid chromatography can separate hemoglobin fractions based on their chromatographic properties. Depending on the analyzer and method, HbA1c may be separated from other hemoglobin fractions and quantified.
HPLC systems can provide additional information about chromatographic patterns, which can be useful when investigating certain abnormal samples or potential hemoglobin variants.
However, interpretation of chromatograms and possible variant interference is method- and analyzer-dependent.
HbA1c by Immunoassay
Immunoassay methods use antibodies directed toward specific structures associated with glycated hemoglobin.
These methods may be integrated into automated laboratory platforms. Their analytical performance and potential interference depend on the specific reagent system and assay design.
HbA1c by Enzymatic Method
Enzymatic HbA1c methods use enzymatic reactions associated with glycated hemoglobin to generate a measurable analytical signal.
As with other HbA1c technologies, calibration, traceability, analytical specificity and method-specific interference must be considered.
HbA1c Calibration, Standardization and Quality Control
From a laboratory perspective, reliable HbA1c measurement depends on more than the analytical instrument alone. Calibration, reagent performance, traceability, internal quality control and external quality assessment contribute to analytical reliability.
- Use an appropriately standardized HbA1c method.
- Follow the manufacturer's calibration procedure.
- Monitor internal quality control performance.
- Investigate shifts and trends in QC results.
- Review calibration status when QC performance changes.
- Participate in appropriate external quality assessment or proficiency testing.
- Follow the laboratory SOP and manufacturer's instructions.
A clinically unexpected HbA1c result should be evaluated together with QC performance, calibration status, method characteristics, patient history and corresponding glucose results.
Why HbA1c and Blood Glucose May Not Match
HbA1c is a weighted indicator of longer-term glucose exposure, whereas a plasma glucose result represents glucose concentration at a particular time.
Therefore, a single glucose measurement does not necessarily equal the HbA1c-derived eAG.
When there is persistent and substantial discordance between glucose results and HbA1c, analytical interference or clinical factors affecting the HbA1c-glycemia relationship should be considered.
Factors That Can Affect HbA1c Results
HbA1c interpretation can be affected by conditions that alter erythrocyte lifespan, hemoglobin characteristics or the analytical measurement. Examples include:
- Hemoglobin variants
- Conditions affecting red blood cell turnover
- Some forms of anemia
- Recent blood loss
- Recent blood transfusion
- Pregnancy
- Glucose-6-phosphate dehydrogenase deficiency
- Elevated fetal hemoglobin
- Other conditions affecting the HbA1c-glycemia relationship
The appropriate response depends on the specific clinical and analytical circumstances.
Hemoglobin Variants and HbA1c
Some hemoglobin variants can interfere with HbA1c measurement depending on the analytical method.
The effect is not necessarily identical across all HbA1c methods. Therefore, laboratories should evaluate method-specific interference information when a hemoglobin variant is suspected.
If HbA1c is inconsistent with the patient's glucose results or clinical picture, review the analytical method, QC performance and potential hemoglobin interference before assuming that the HbA1c result reflects true glycemic exposure.
Why NGSP Certification Matters
For diagnostic HbA1c testing, the ADA recommends a method certified by NGSP and traceable to the DCCT reference assay.
Standardization helps improve comparability of HbA1c results between laboratories and supports the use of established diagnostic thresholds.
HbA1c vs Fasting Plasma Glucose
| Feature | HbA1c | Fasting Plasma Glucose |
|---|---|---|
| Reflects | Weighted longer-term glucose exposure | Glucose concentration at a specific fasting time |
| Fasting required | Generally no | Yes |
| Common unit | % or mmol/mol | mg/dL or mmol/L |
| RBC-related factors | Can affect interpretation | No direct RBC dependence |
Advantages of HbA1c Testing
- Fasting is generally not required.
- Provides longer-term information about glycemic exposure.
- Useful for diabetes diagnosis when appropriate criteria are satisfied.
- Useful for monitoring glycemic management.
- Can be reported using standardized NGSP and IFCC systems.
Limitations of HbA1c
- Results can be affected by altered red blood cell turnover.
- Some hemoglobin variants can interfere with specific methods.
- HbA1c does not represent a direct glucose measurement.
- HbA1c may not accurately represent glycemia in certain clinical conditions.
- Results close to diagnostic thresholds may require confirmation.
- Different analytical methods can have different interference characteristics.
Frequently Asked Questions About HbA1c
What is HbA1c?
HbA1c is glycated hemoglobin and is used as a laboratory marker of longer-term glycemic exposure.
What is a normal HbA1c?
For nonpregnant individuals, an HbA1c below 5.7% is below the prediabetes range. Values from 5.7% to 6.4% are classified as prediabetes.
What HbA1c level indicates diabetes?
An HbA1c of 6.5% or higher meets the diabetes diagnostic threshold when appropriate standardized testing and confirmation requirements are satisfied.
What is NGSP HbA1c?
NGSP HbA1c is reported using the National Glycohemoglobin Standardization Program system and is commonly expressed as a percentage.
What is IFCC HbA1c?
IFCC HbA1c is reported in mmol/mol using the IFCC reference system.
What is the difference between NGSP and IFCC HbA1c?
NGSP commonly reports HbA1c as a percentage, while IFCC reports HbA1c in mmol/mol. The two systems are linked through an established mathematical relationship.
What is eAG?
eAG means estimated average glucose. It is an HbA1c-derived estimate of average glucose commonly reported in mg/dL or mmol/L.
How is eAG calculated from HbA1c?
The ADAG relationship reported by NGSP is: eAG (mg/dL) = 28.7 × HbA1c − 46.7.
Does HbA1c require fasting?
HbA1c testing generally does not require fasting.
Can anemia affect HbA1c?
Conditions that alter red blood cell turnover can affect the relationship between HbA1c and glycemic exposure. HbA1c should therefore be interpreted carefully in such situations.
Can hemoglobin variants affect HbA1c?
Yes. Some hemoglobin variants can interfere with particular HbA1c methods. The effect depends on the specific variant and analytical method.
Can I calculate eAG from HbA1c online?
Yes. The LabProSuite HbA1c to eAG Calculator calculates estimated average glucose in mg/dL and mmol/L.
Calculate HbA1c to eAG
Convert HbA1c into estimated average glucose using the ADAG equation.
Open HbA1c to eAG Calculator →References
- American Diabetes Association. Standards of Care in Diabetes—2026. Diagnosis and Classification of Diabetes.
- National Glycohemoglobin Standardization Program (NGSP). HbA1c Standardization and Estimated Average Glucose.
- NGSP. IFCC Standardization of HbA1c.
- Nathan DM, et al. Translating the A1C Assay Into Estimated Average Glucose Values. Diabetes Care.
Disclaimer
This article is intended for educational and laboratory reference purposes only. It does not replace professional medical evaluation, diagnosis, treatment, laboratory SOPs or manufacturer instructions.
HbA1c results should be interpreted together with clinical information, other laboratory findings, analytical method characteristics and appropriate professional judgment.
